Joi Carter, MD

Joi Carter headshot

Undergraduate:
College of The Holy Cross

Medical School:
Dartmouth Medical School

Internship:
Beth Israel Deaconess Medical Center, Internal Medicine

Residency:
Dartmouth-Hitchcock Medical Center, Dermatology

Fellowship:
Brigham and Women’s Hospital and Dana Farber Cancer Institute, Cutaneous Oncology

Dr. Carter completed residency in Dermatology at Dartmouth Hitchcock Medical Center and pursued specialty training via Cutaneous Oncology Fellowship at Dana Farber Cancer Center/Brigham and Women’s Hospital. In 2015 she returned to her roots in New Hampshire and joined the Dermatology faculty at DHMC and Geisel School of Medicine at Dartmouth. At DHMC she participates in the multidisciplinary cutaneous lymphoma clinic and is co-founder of the first High Risk Skin Cancer Clinic at DHMC. In addition, she is the Residency Program Director for Dermatology Residents.

My dermatology practice focuses on skin cancer. In particular, I see patients with rare lymphomas of the skin (cutaneous T cell lymphoma or cutaneous B cell lymphoma) as well as patients who are at high risk of developing skin cancer due to either a suppressed immune system (organ transplant recipients or patients with chronic lymphocytic leukemia) or other genetic factors. I enjoy collaborating with other specialists to provide coordinated multidisciplinary care and working with patients to create a skin cancer management and prevention plan that best fits their needs.

I am a member of the United States Cutaneous Lymphoma Consortium as well as the International immunosuppression and Transplant Skin Cancer Collaborative and continue to actively collaborate with physicians who have similar interests. I am grateful to be able to develop relationships with and learn from my patients over time, teach residents and medical students about rare skin disorders, and participate in research to help advance our knowledge within the field of cutaneous oncology. "

Professional Interests:
Cutaneous Oncology, Cutaneous T cell lymphoma, Cutaneous B cell lymphoma, High risk skin cancer, Cutaneous care of transplant recipients, Melanoma

Personal Interest:
Hiking, Snowshoeing, Volleyball, Spending time with family

Selected Publications: 

  • Clark RA, Watanabe R, Teague JE, Schlapbach C, Tawa MC, Adams N, Dorosario AA, Chaney KS, Cutler CS, Leboeuf NR, Carter JB, Fisher DC, Kupper TS. Skin effector memory T cells do not recirculate and provide immune protection in alemtuzumab treated CTCL patients. Sci Transl Med. 2012 Jan 18;4(117):117ra7
  • Carter JB, Johnson MM, Chua TL, Karia PS, Schmults CD. Outcomes of primary cutaneous squamous cell carcinoma with perineural invasions: an 11-year cohort study. JAMA Dermatol. 2013 Jan;149(1):35-41.
  • Olsen EA, Hodak E, Anderson T, Carter JB, Henderson M, Cooper K, Lim HW. Guidelines for phototherapy of mycosis fungoides and Sezary syndrome: A consensus statement of the United States Cutaneous Lymphoma Consortium. J Am Acad Dermatol. 2016 Jan; 74(1): 27-58

 

Geisel School of Medicine Faculty Profile